Fangfang Li
Impact in
-
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
-
- Electrospun Nanofibers in Biomedical Applications
Papers in
-
- Signaling Pathways in Disease 2
- RNA Research and Splicing 2
- Microbial Metabolic Engineering and Bioproduction 2
-
- Bone Tissue Engineering Materials 2
- Biofuel production and bioconversion 2
- Co-authors
- Limin Dong (2 shared papers)Liang‐Hong Guo (1 shared paper)Monika Mortimer (1 shared paper)Qiufei Xie (2 shared papers)Tao Fang (1 shared paper)Wenqian Huang (1 shared paper)Juan Wang (1 shared paper)Xixi Li (1 shared paper)
- Journals
- International Journal of Molecular Sciences (2 papers)Scientific Reports (1 paper)Materials Science and Engineering C (1 paper)Naunyn-Schmiedeberg s Archives of Pharmacology (1 paper)Cell Death and Disease (1 paper)
- Partner nations
- ChinaUnited StatesUnited Kingdom
In The Last Decade
Fangfang Li
23 papers receiving 379 citations
Peers
Comparison fields: 5 of 90
- Cancer Research 64
- Biomaterials 41
- Molecular Biology 170
- Oral Surgery 17
- Biomedical Engineering 97
Countries citing papers authored by Fangfang Li
This map shows the geographic impact of Fangfang Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fangfang Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fangfang Li more than expected).
Fields of papers citing papers by Fangfang Li
This network shows the impact of papers produced by Fangfang Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fangfang Li. The network helps show where Fangfang Li may publish in the future.
Co-authors
The 25 scholars most cited alongside Fangfang Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 24 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 48 | |
| 2 | 2013 | 44 | |
| 3 | 2018 | 44 | |
| 4 | 2019 | 42 | |
| 5 | 2020 | 37 | |
| 6 | 2016 | 22 | |
| 7 | 2020 | 18 | |
| 8 | 2019 | 17 | |
| 9 | 2015 | 16 | |
| 10 | 2014 | 14 | |
| 11 | 2018 | 14 | |
| 12 | 2020 | 11 | |
| 13 | 2014 | 10 | |
| 14 | 2021 | 10 | |
| 15 | 2021 | 9 | |
| 16 | 2019 | 8 | |
| 17 | 2021 | 5 | |
| 18 | [Identification of dominant and fragrance-enhancing microorganisms of tobacco leaves during ripening]. | 2009 | 4 |
| 19 | 2024 | 3 | |
| 20 | 2022 | 2 |
About Fangfang Li
Fangfang Li is a scholar working on Molecular Biology, Biomedical Engineering, Pulmonary and Respiratory Medicine, Biotechnology and Cancer Research, having authored 24 papers that have together received 381 indexed citations. Recurring topics across this work include Signaling Pathways in Disease (2 papers), RNA Research and Splicing (2 papers), Bone Tissue Engineering Materials (2 papers), MicroRNA in disease regulation (2 papers), GABA and Rice Research (2 papers), Microbial Metabolic Engineering and Bioproduction (2 papers), Biofuel production and bioconversion (2 papers) and Williams Syndrome Research (1 paper). The work is most often cited by research in Cancer Research (64 citations), Biomaterials (41 citations), Molecular Biology (170 citations), Oral Surgery (17 citations) and Biomedical Engineering (97 citations). Fangfang Li has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Limin Dong, Liang‐Hong Guo, Monika Mortimer, Qiufei Xie, Tao Fang, Wenqian Huang, Juan Wang, Xixi Li, Xia Deng and Wenjie Wei. Their work appears in journals such as International Journal of Molecular Sciences, Scientific Reports, Materials Science and Engineering C, Naunyn-Schmiedeberg s Archives of Pharmacology and Cell Death and Disease.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.